点击图片查看原图
份 库存999份
| 货号： | OAAB17751 |
| 抗体英文名： | MAP3K13 Antibody - N-terminal region (OAAB17751) |
| 靶点： | MAP3K13 |
| 应用范围： | WB |
| 宿主： | Mouse |
| 适应物种： | Human |
| 克隆性： | 否 |
| 保存条件： | Maintain refrigerated at 2-8C for up to 6 months. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles. |
| 形态： | Liquid. Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. |
| 亚型： | IgM |
| 规格： | 400 ul |
Swissprot Id: O43283
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. - See more at: http://www.avivasysbio.com/sd/tds/html_datasheet.php?sku=OAAB17751
NCI-H460 cell line lysates (35ug/lane)
MAP3K13 (LZK) Antibody (C-term) (Cat. #OAAB17751) western blot analysis in NCI-H460 cell line lysates (35ug/lane).
This demonstrates the MAP3K13 (LZK) antibody detected the MAP3K13 (LZK) protein (arrow).
Dilution: 1:1000
温馨提示：不可用于临床治疗。
通过大兴分局认证 
